BMJ2d
Influence of elastic bandage on knee pain, proprioception, and postural sway in subjects with knee osteoarthritis
Correspondence to: Professor M Doherty, Academic Rheumatology, Clinical Sciences Building, University of Nottingham, City Hospital, Hucknall Road, Nottingham NG5 1PB, UK; Michael.Doherty{at}Nottingham ...
BMJ3d
Mechanical overloading promotes chondrocyte senescence and osteoarthritis development through downregulating FBXW7
Objectives To investigate the role of mechanical stress in cartilage ageing and identify the mechanistic association during osteoarthritis (OA) progression. Conclusions FBXW7 is a key factor in the ...
BMJ3d
POS1604 IL-13 INHIBITION USED FOR ATOPIC DISEASES IS ASSOCIATED WITH RISK OF PSORIATIC ARTHRITIS
1 University of Manchester, Centre for Epidemiology Versus Arthritis, Manchester, United Kingdom 2 Manchester University NHS Foundation Trust, NIHR Manchester Biomedical Research Centre, Manchester, ...
BMJ3d
Global, regional and national burden of osteoarthritis 1990-2017: a systematic analysis of the Global Burden of Disease Study 2017
Objectives To report the level and trends of prevalence, incidence and years lived with disability (YLDs) for osteoarthritis (OA) in 195 countries and territories from 1990 to 2017 by age, sex and ...
BMJ3d
Characterising arthralgia in the preclinical phase of rheumatoid arthritis using MRI
Correspondence to HW van Steenbergen, Department of Rheumatology, Leiden University Medical Center, P O Box 9600, Leiden 2300 RC, The Netherlands; h.w.van_steenbergen{at}lumc.nl Background The phase ...
BMJ3d
AB0146 HAND AND WRIST ACTIVE RANGE OF MOTIONS AND CONTRIBUTING FACTORS IN RHEUMATOID ARTHRITIS: A CROSS-SECTIONAL STUDY
Background: Patients with rheumatoid arthritis (RA) usually impaired range of motions (ROMs), especially hand and wrist active ROMs (AROMs), thus influencing their ability to perform daily activities ...
BMJ3d
AB0546 5 YEARS FOLLOW-UP OF PSORIATIC ARTHRITIS PATIENTS TREATED ACCORDING TREAT-TO-TARGET STRATEGY. PRELIMINARY RESULTS
1 V. A. Nasonova Research Institute of Rheumatology, Spondyloarthritis and psoriatic arthritis, Moscow, Russian Federation 2 V. A. Nasonova Research Institute of Rheumatology, medical and social ...
BMJ3d
2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus
Correspondence to Martin Aringer, Medicine III, University Medical Center and Faculty of Medicine Carl Gustav Carus, TU Dresden, Dresden D-01307, Germany; martin.aringer{at}uniklinikum-dresden.de; Dr ...
BMJ3d
Adalimumab dose tapering in patients with rheumatoid arthritis who are in long-standing clinical remission: results of the phase IV PREDICTRA study
Objective To investigate the association between baseline disease activity and the occurrence of flares after adalimumab tapering or withdrawal in patients with rheumatoid arthritis (RA) in sustained ...
BMJ4d
Ultrasensitive serum interferon-α quantification during SLE remission identifies patients at risk for relapse
1 Sorbonne Université, Assistance Publique–Hôpitaux de Paris, Groupement Hospitalier Pitié–Salpêtrière, French National Referral Center for Systemic Lupus Erythematosus, Antiphospholipid Antibody ...
BMJ4d
POS0145 CLINICAL AND PATHOGENIC SIGNIFICANCE OF S100A4 OVEREXPRESSION IN SYSTEMIC SCLEROSIS
Background S100A4 belongs to a family of proteins originally defined by solubility of the prototypic members in 100% saturated ammonium sulphate. Preclinical studies suggest that extracellular S100A4 ...
BMJ4d
Mortality and causes of death in a Swedish series of systemic sclerosis patients
OBJECTIVES To analyse survival rates and the causes of death in a systemic sclerosis (SSc) population, and to evaluate the occurrence of fatal malignant neoplasms and their possible association with ...